Next Article in Journal
Evaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum
Next Article in Special Issue
Editorial for the Topical Collection “SARS-CoV-2 Infection and COVID-19 Disease”
Previous Article in Journal
Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice
Previous Article in Special Issue
The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups
 
 
Review

Article Versions Notes

Pathogens 2023, 12(7), 862; https://doi.org/10.3390/pathogens12070862
Action Date Notes Link
article pdf uploaded. 22 June 2023 15:15 CEST Version of Record https://www.mdpi.com/2076-0817/12/7/862/pdf-vor
article xml file uploaded 25 June 2023 11:31 CEST Original file -
article xml uploaded. 25 June 2023 11:31 CEST Update https://www.mdpi.com/2076-0817/12/7/862/xml
article pdf uploaded. 25 June 2023 11:31 CEST Updated version of record https://www.mdpi.com/2076-0817/12/7/862/pdf
article html file updated 25 June 2023 11:33 CEST Original file https://www.mdpi.com/2076-0817/12/7/862/html
Back to TopTop